Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Tampa, Florida Clinical Trials

A listing of Tampa, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (51) clinical trials

A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment

This postmarketing study is a randomized, double-blind, placebo-controlled study to evaluate safety (with particular focus on renal and cardiovascular events) and efficacy of lesinurad 200 mg QD in combination with an XOI for up to 24 months compared with XOI monotherapy, in participants with gout and moderate renal impairment who ...

Phase

1.75 miles

Learn More »

Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use

This study will evaluate the efficacy and safety of eluxadoline 100 milligrams (mg) twice a day (BID) versus placebo for the treatment of patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) who report that the use of loperamide in the prior 12 months failed to provide control of their IBS-D ...

Phase

1.75 miles

Learn More »

The purpose of the study is to determine whether H.P. Acthar® Gel (repository corticotropin injection) is helpful for adult patients with FSGS who still have an abnormal amount of protein in their urine, despite prior treatment.

Phase

4.68 miles

Learn More »

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

This study is designed to evaluate the efficacy and safety of tofacitinib modified release formulation (11mg QD) versus tofacitinib modified release formulation plus continued methotrexate treatment in subjects with moderate to severe rheumatoid arthritis who are insufficiently responding to their stable dose of methotrexate treatment.

Phase

4.88 miles

Learn More »

Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation

This is a multicenter study in adult patients with AF and ESRD who are on hemodialysis and who have stroke risk factors making them candidates for oral anticoagulation. Patients will be randomized to apixaban versus warfarin, and will be treated for up to 15 months.

Phase

4.88 miles

Learn More »

Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS

Multicenter, multiple dose study to examine the effect of H.P. Acthar Gel (repository corticotropin injection) in adult subjects with idiopathic focal segmental glomerulosclerosis (FSGS) who have failed to achieve remission with, or who are intolerant of, 1 or more previous immunosuppressive therapies.

Phase

4.88 miles

Learn More »

Patient Inclusion Criteria: Ages 18-70 21 Day Washout of all spasticity medications Has multiple sclerosis (MS) based on Poser or McDonald Criteria (all subtypes of MS will be accepted, including relapsing remitting, primary or secondary progressive, if disease is stable per exclusion criteria). Expanded Disability Status Scale (EDSS) rating between ...

Phase

5.95 miles

Learn More »

Patient Inclusion Criteria: Ages 18+ RLS diagnosis 15 nights or more in past month with RLS symptoms Must stop all RLS medications 2 weeks prior No Horizant usage in past Men or women 18 years of age or older History of RLS symptoms for at least 15 nights/month Documented RLS ...

Phase

5.95 miles

Learn More »

Patient Inclusion Criteria: Ages 18-65 No MS relapses required for study entry Written informed consent must be obtained prior to any assessment being performed. Male and female patients aged 18-65 years inclusive. Patients diagnosed with relapsing remitting MS, defined by the 2010 revised McDonald criteria EDSS score of less than ...

Phase

5.95 miles

Learn More »

Patient Inclusion Criteria: Ages 18-65 1 Relapse in Past Year/2 Relapses in Past 2 years No Assistive Device to Walk/Use Cane but can walk 500 meters with C Written informed consent must be obtained before any assessment is performed Male and female patients 18 to 65 years of age, inclusive. ...

Phase

5.95 miles

Learn More »